CMBM stock results show that Cambium Networks missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
Articles
FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q1 2024
FATE stock results show that Fate Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
REFR Stock Earnings: Research Frontiers Reported Results for Q1 2024
Research Frontiers just reported results for the first quarter of 2024. More
XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024
XENE stock results show that Xenon Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. More
PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024
PODD stock results show that Insulet beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
